+ All Categories
Home > Documents > Global Benchmarking

Global Benchmarking

Date post: 14-Jan-2016
Category:
Upload: zinna
View: 38 times
Download: 0 times
Share this document with a friend
Description:
Global Benchmarking. Global Benchmarking. Canada receives a D grade in innovation & ranks 13 th out of 17 th in OECD Relative comparative decline in average health status, from 5 th to 10 th. Global Benchmarking. Higher % of R&D from government - PowerPoint PPT Presentation
Popular Tags:
17
Transcript
Page 1: Global Benchmarking
Page 2: Global Benchmarking

Global BenchmarkingGlobal Benchmarking

Page 3: Global Benchmarking

Global Benchmarking

- Canada receives a D grade in Canada receives a D grade in innovation & ranks 13innovation & ranks 13thth out of 17 out of 17thth in in OECDOECD

- Relative comparative decline in Relative comparative decline in average health status, from 5average health status, from 5thth to 10 to 10thth

Page 4: Global Benchmarking

Global BenchmarkingGlobal Benchmarking

- Higher % of R&D from governmentHigher % of R&D from government

- Produces lots of scientific discovery Produces lots of scientific discovery and lots of small companies w/o and lots of small companies w/o critical mass to compete globallycritical mass to compete globally

Page 5: Global Benchmarking

Issues For Issues For Northern OntarioNorthern Ontario

– Lack of comparative critical mass of Lack of comparative critical mass of companies and supporting companies and supporting infrastructureinfrastructure

– Geography limits cooperation, Geography limits cooperation, networking & service deliverynetworking & service delivery

Page 6: Global Benchmarking

Issues For Issues For Northern OntarioNorthern Ontario

- Comprehensive health sector industrial Comprehensive health sector industrial strategy?strategy?

- Canada Health Act is a double edged Canada Health Act is a double edged psychological sword!psychological sword!

Page 7: Global Benchmarking

Additional IssuesAdditional Issues

• Higher morbidity ratesHigher morbidity rates

• Poor understanding of the nature of Poor understanding of the nature of health research including its health research including its corresponding commercialization corresponding commercialization pathwayspathways

Page 8: Global Benchmarking

Additional IssuesAdditional Issues

• Scarce funding resourcesScarce funding resources

• Business model must focus on both Business model must focus on both prevention and management of chronic prevention and management of chronic diseasedisease

Page 9: Global Benchmarking

HOT SPOTSHOT SPOTS

• Molecular medicine: mitochondrial Molecular medicine: mitochondrial DNA, genetic DNA analysisDNA, genetic DNA analysis

• Miscellaneous genetic research Miscellaneous genetic research applicationsapplications

Page 10: Global Benchmarking

HOT SPOTSHOT SPOTS

• Cancer research – including diagnosis, Cancer research – including diagnosis, staging and treatment platformsstaging and treatment platforms

• A variety of eclectic research initiatives A variety of eclectic research initiatives from NOSM, including natural and from NOSM, including natural and traditional pharmacological sourcestraditional pharmacological sources

Page 11: Global Benchmarking

HOT SPOTSHOT SPOTS

• Telemedicine and rural service deliveryTelemedicine and rural service delivery

• World class clinical trial expertise and World class clinical trial expertise and capacitycapacity

• Health care informatics/medical Health care informatics/medical geographygeography

Page 12: Global Benchmarking

Additional OpportunitiesAdditional Opportunities

• Health promotionHealth promotion

• Targeted bioprospecting of forest and Targeted bioprospecting of forest and agriculture based substancesagriculture based substances

• Nutraceuticals and Functional FoodsNutraceuticals and Functional Foods

Page 13: Global Benchmarking

Additional OpportunitiesAdditional Opportunities

• Clinical research organizations: Clinical research organizations: traditional and specialized eg. traditional and specialized eg. evaluating the safety and efficacy of evaluating the safety and efficacy of nutritional therapiesnutritional therapies

• Toll manufacturing opportunities eg. Toll manufacturing opportunities eg. devices, drug delivery systems, devices, drug delivery systems, nutraceuticals, biologicals?nutraceuticals, biologicals?

Page 14: Global Benchmarking

Additional OpportunitiesAdditional Opportunities

• Development of medical devicesDevelopment of medical devices

• Delivery system technologiesDelivery system technologies

• Integrated patient and clinical data Integrated patient and clinical data systemssystems

Page 15: Global Benchmarking

STRATEGYSTRATEGY

ResourcesResources

& Assets& AssetsInfrastructureInfrastructure

Existing & New Existing & New Project Project

OpportunitiesOpportunities

Page 16: Global Benchmarking

What’s NeededWhat’s Needed

A focused but integrated health A focused but integrated health strategy which targets innovative strategy which targets innovative therapies, products and services with therapies, products and services with the long term goal to improve both the the long term goal to improve both the health status of Northerners and to health status of Northerners and to generate the wealth to finance ongoing generate the wealth to finance ongoing programs and R&Dprograms and R&D

Page 17: Global Benchmarking

Recommended